The Rh blood-group antigens are associated with human erythrocyte membrane proteins of approx. 30 kDa (the Rh30 polypeptides). Heterogeneously glycosylated membrane proteins of 50 and 45 kDa (the Rh50 glycoproteins) are coprecipitated with the Rh30 polypeptides on immunoprecipitation with anti-Rh-specific mono-and poly-clonal antibodies. We have isolated cDNA clones representing a member of the Rh,0 glycoprotein family (the Rh50A glycoprotein). We used PCR with degenerate primers based on the N-terminal amino acid sequence of the Rh50 glycoproteins and human genomic DNA as a template and cloned and sequenced three types of PCR product of the expected size. Two of these products, Rh5OA and Rh50B, gave the same translated amino acid sequence which corresponded to the expected Rh50 glycoprotein sequence but had only 75 % DNA sequence similarity. The third product (Rh50C) contained a single base deletion, and the translated amino acid sequence contained an in-frame stop codon. We have isolated cDNA clones containing the full coding sequence of the Rh50A glycoprotein. This sequence predicts that it is a 409-amino acid N-glycosylated membrane protein with up to 12 transmembrane domains. The Rh5OA glycoprotein shows clear similarity to the Rh3OA protein in both amino acid sequence and predicted topology. Our results are consistent with the Rh30 and Rh50 groups of proteins being different subunits of an oligomeric complex which is likely to have a transport or channel function in the erythrocyte membrane. We mapped the Rh50A gene to human chromosome 6p21-qter, showing that genetic differences in the Rh30 rather than the Rh5O genes specify the major polymorphic forms of the Rh antigens.
INTRODUCTION
The human Rh blood-group antigens are of importance in blood transfusion and immunohaematology because of their high antigenicity in man and their involvement in haemolytic disease of the newborn (Mollison et al., 1987) . The detailed structure of the many antigens of the Rh blood group system is still unknown, but recent identification of some of the polypeptides involved in the expression of these antigens has allowed progress in their sequence and structural characterization.
Immunoprecipitation studies using anti-c, D or E sera and Rhrelated mouse monoclonal antibodies of the R6A type (which react with erythrocytes of all phenotypes except Rhnu,,) have identified two Rh-related erythrocyte membrane polypeptides of 30 and 32 kDa (Moore et al., 1982; Gahmberg, 1982; Ridgwell et al., 1983; Moore & Green, 1987; Aventet al., 1988a; Blanchard et al., 1988) , denoted the D30and R6A32 polypeptides respectively. These 30 kDa integral membrane proteins are not glycosylated (Moore et al., 1982; Gahmberg, 1982) . The N-terminal amino acid sequence of both polypeptides has been determined (Avent et al., 1988b; Bloy et al., 1988; Saboori et al., 1988) and cDNA clones corresponding to one of them (designated Rh30A, which most likely represents the R6A32 polypeptide) have been isolated (Avent et al., 1990; Cherif-Zahar et al., 1990) . The Rh3OA polypeptide contains 417 amino acids and is a very hydrophobic protein with up to 12 membrane-spanning segments.
In addition to the 30 kDa polypeptides described above, immunoprecipitates obtained using anti-Rh-specific antibodies or the R6A type of mouse monoclonal antibodies also contain higher-molecular-mass. glycoproteins which migrate as broad bands on SDS/PAGE because of heterogeneity in their glycan chains (Moore & Green, 1987; Avent et al., 1988a,b) . A glycoprotein of molecular mass 45-100 kDa (the D50 glycoprotein) is obtained together with the D30 polypeptide on immunoprecipitation with anti-D antibodies. Similarly, a glycoprotein of 35-52 kDa (the R6A45 glycoprotein) is immunoprecipitated together with the R6A32 polypeptide when the R6A type of antibody is used. The amino acid sequence of the D50 polypeptide has been determined up to residue 39 although residue 2 could not be assigned (Avent et al., 1988b) . The R6A45 glycoprotein gave the same N-terminal amino acid sequence up to residue 30 except that amino residue 2 was assigned as cysteine (Avent et al., 1988b) . The N-terminal amino acid sequence of the D50/R6A45 glycoproteins (collectively described here as the Rh50 glycoproteins) differed from that of the D30/R6A32 polypeptides (collectively described here as the Rh30 polypeptides), although the sequences of the two groups of proteins showed some similarity (Avent et al., 1988b) . The coprecipitation of these two groups of proteins suggested that they may be associated in the erythrocyte membrane.
We describe here the sequence of a cDNA clone for a member of the Rh50 group of glycoproteins which we denote the Rh5OA glycoprotein. The cDNA predicts that the Rh5OA glycoprotein is a very hydrophobic integral membrane protein which is likely to be glycosylated at two of three potential N-glycan addition sites. The amino acid sequence of the protein is related to that of the Rh30A polypeptide and it is likely to have a structure and topology in the membrane which is very similar to the Rh3OA polypeptide (Avent et al., 1990; Cherif-Zahar et al., 1990) . The association between the two proteins and their similarity in structure are consistent with earlier suggestions that they are subunits of a functional complex in the erythrocyte membrane (Avent et al., 1988a; Anstee & Tanner, 1988; Agre & Cartron, 1991) .
MATERIALS AND METHODS
PCR amplification, and cloning and sequencing of PCR products D50 and R6A45 polypeptides were purified and sequenced as described by Avent et al. (1988b) . PCR was carried out using human genomic DNA as a template and Amplitaq Taq polymerase (Perkin-Elmer/Cetus Corp., Norwalk, CT, U.S.A.) according to the manufacturer's instructions. The forward degenerate primer corresponded to amino acid residues 1-9 of the D50 glycoprotein sequence (Avent et al., 1988b) and had the DNA sequence 5'-ATGTGCTTCACXTTC/TCCXC/ TTXATGGC-3'. The reverse primer corresponded to amino acid residues 23-21 ofthe D50 glycoprotein and had the DNA sequence 5'-GTCTGGTCXGTC/TTCA/GTAC/TTCXACG/AAA-3'. The expected 92 bp product was obtained using 30 cycles of amplification, and was purified by PAGE, ligated into the Bluescript phagemid (Stratagene Cloning Systems, San Diego, CA, U.S.A.) and sequenced using the Sequenase Version 2.0 DNA sequencing kit (U.S.B. Corp., Cleveland, Ohio, U.S.A.) according to the manufacturer's instructions. Isolation and sequencing of Rh5O cDNA clones Two oligonucleotides were prepared corresponding to nucleotides 4-31 of the unique sequence found for the Rh5OA PCR product and nucleotides 7-31 of the unique sequence of Rh5OB PCR product shown in Fig. 1 . Each was separately radiolabelled at the 5' end using polynucleotide kinase (Amersham International, Amersham, Bucks., U.K.) and purified by elution from a 20 % denaturing polyacrylamide gel (Sambrook et al., 1989) . The labelled oligonucleotides were used separately to screen a number of human cDNA libraries. Only the Rh50A-specific oligonucleotide yielded positive clones and these were obtained from a bone marrow AgtlO cDNA library and a fetal liver Agtll cDNA library (Clontech Laboratories, Palo Alto, CA, U.S.A.). The inserts in the AgtlO clones were excised with restriction endonucleases as described in the text, subcloned into Bluescript and sequenced as described above. The insert in the fetal liver library Agtl 1 clone was subcloned after PCR amplification using Agtl 1 forward and reverse primers (New England Biolabs Inc., Beverly, MA, U.S.A.) and blunt-end ligation into Bluescript. Double-stranded sequencing of the insert in the AB2 cDNA clone Phage DNA was isolated and purified by caesium chloride centrifugation using standard techniques (Sambrook et al., 1989 Fig. 2 ). Three different reverse primers were used and these had sequences corresponding to the reverse complement of nucleotides [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] or 360-380 of the Rh5OA cDNA (see Fig. 2 ). PCR products of the predicted sizes were obtained, purified by PAGE and used as templates for 40 cycles of asymmetric PCR (Gyllensten, 1989 ) with a 50-fold excess of the forward primer. The single-stranded asymmetric PCR products were purified by ultrafiltration (Centricon 30, Amicon, Beverly, MA, U.S.A.) before DNA sequencing.
Chromosomal localization of the Rh5OA gene Genomic DNA was isolated on an Applied Biosystems 340A DNA extractor according to the supplied protocols. Standard procedures were used for restriction enzyme digestion and Southern blotting of the genomic DNA and for hybridization with radiolabelled probes (Sambrook et al., 1989) . The 1.87 kb BlA EcoRI fragment was used as a probe and was radiolabelled by random oligonucleotide priming (Feinberg & Vogelstein, 1984) . The culture and characterization ofhuman-rodent somatic cell hybrids have been previously described (Spurr et al., 1986) .
RESULTS AND DISCUSSION
Cloning and sequencing of Rh5 glycoprotein partial cDNAs using PCR We previously reported the N-terminal amino acid sequences of the D50 and R6A45 polypeptides up to residues 39 and 30 respectively (Avent et al., 1988b) . Mixed-sequence degenerate oligonucleotides based on this amino acid sequence were used for PCR amplification, and products of the predicted 92 bp size were isolated. When these products were cloned and sequenced, three different DNA sequences were found in the region between the 3' ends of the primers. Two of these (Rh5OA and Rh5OB, Fig. 1 ) had only 75 % DNA sequence similarity but when translated gave the same amino acid sequence and this corresponded to that found for the Rh5O glycoproteins. The third PCR product (Rh5OC, Fig. 1 ) had the same sequence as Rh5OB but a single nucleotide change and a single nucleotide deletion introduced an in-frame stop codon at amino acid residue 13 which would result in a truncated amino acid sequence. This DNA sequence may result from PCR misincorporation errors or it may be the product of a pseudogene in the Rh5O gene family. These data suggest that there may be at least two genes for the Rh5O family of glycoproteins. Isolation and sequencing of Rh5OA cDNA clones Oligonucleotides corresponding to the unique sequence be-10 15 20
Fig. 1. DNA sequence and translated amino acid sequence of cloned PCR products The DNA sequence and translated amino acid sequence of the cloned Rh5OA, Rh5OB and Rh5OC PCR products in the region between the 3' ends of the primers. At least three independent clones of each type were sequenced. tail, the B1A clone from nucleotide 34 to the 3' poly(A) tail, and the B2 clone contains the whole coding sequence and 3' non-coding region, and 27 nucleotides of 5' upstream sequence. The DNA sequence is numbered so that nucleotide 1 corresponds to the initiator methionine codon of the protein. (Fig. 2) . The translated amino acid sequence of the combined BlA and Fl cDNAs (which extends from nucleotide 22 in Fig. 2 ) corresponded almost exactly to the known N-terminal amino acid sequence of the Rh5o polypeptides from Met-8 to Thr-39 except that residues 37 and 38 are predicted to be Asn-Ile from the cDNA sequence but were assigned as Pro-X on amino acid sequencing of the isolated D50 glycoproteins (Avent et al., 1988b) . Asn-37 is likely to be Nglycosylated (see below) and the presence of the glycosylated residue may have given rise to the amino acid misassignment. Although a 2.2 kb insert (B2) was obtained on EcoRI digestion of the AB2 clone, we were unsuccessful in several attempts to subclone this EcoRI fragment in two different plasmid vectors and using two different bacterial hosts. We confirmed that the AB2 insert was related to the B1A and Fl cDNAs by sequencing of the 3' end of the insert in the intact AB2 clone, and this showed that the insert contained nucleotides 1624-1854 of the Rh5OA cDNA with an A1o tract at the 3' end. The 1680 nucleotides of the 5' end of the B2 insert were subcloned and sequenced as part of a HindlIl fragment of the intact AB2 phage DNA. The nucleotide sequence of the B2 cDNA was the same as that of the BIA cDNA where they overlapped, with G at nucleotide 724 predicting Asp-242, as was found in the BIA cDNA (Fig. 2) (Wilbur & Lipman, 1983). found in the other cDNAs). The 5' region of the B2 cDNA was found to contain additional sequence which extended from the 5' side of that shown in Fig. 2 . This sequence comprised an inverted repeat of nucleotides 1-122 in Fig. 2 and a poly(T) region at the extreme 5' end, both of which were probably the result of cloning artefacts. The Rh5OA cDNA sequence compiled from the BIA, B2 and Fl cDNAs is shown in Fig. 2 . In order to confirm that amino acid residue 2 was arginine in the Rh5OA glycoprotein, a sense oligonucleotide primer was synthesized corresponding to nucleotides -19 to -2 (Fig. 2) . This was employed in the PCR with one of several different reverse primers which matched the coding sequence in Fig. 2 The cDNA clones predict a protein (Fig. 2) which corresponds to the Rh50 glycoprotein sequence from residue 1 to 39 except that there is an arginine instead of a cysteine residue at position 2, and Asn-Ile instead of Pro-Xaa at residues 37 and 38. We attempted to establish the amino acid at residue 2 by further Nterminal amino acid sequencing using the Edman degradation on an additional three samples of the R6A45 glycoprotein. One sample of R6A45 immunoprecipitate obtained using monoclonal antibody BRIC 69 (Avent et al., 1988a) gave arginine at amino acid residue 2. We were unable to assign the amino acid at residue 2 in the other two samples but no evidence for the presence of cysteine was found.
Structure of the Rh5OA glycoprotein and relationship to Rh3OA polypeptide
The 409-amino acid Rh5OA glycoprotein sequence predicted from the cDNA contains three potential N-glycan addition sites at Asn-37, Asn-274 and Asn-355. The D50 and R6A45 polypeptides are known to be highly glycosylated, giving diffuse bands on SDS/PAGE and showing a marked decrease in size to a sharp band of approx. 30 kDa after treatment with endoglycosidase-F preparations (Moore & Green, 1987; Avent et al., 1988a) . The deglycosylated R6A45 protein was similar in size to the Rh30 polypeptide.
Hydropathy analysis suggests that the Rh5OA glycoprotein may have 12 membrane-spanning domains (Fig. 3a) and shows the overall hydrophobic nature of the polypeptide. Alignment of the amino acid sequence of the Rh5OA glycoprotein with that of the Rh3OA polypeptide shows a high degree of sequence similarity between the proteins (Fig. 3c) . The hydropathy plots for the two proteins are also very similar (Figs. 3a and 3b) , with each being predicted to have the same number of membrane-spanning domains in similar locations. The regions of highest sequence similarity between the proteins tend to be located in these putative membrane-spanning domains (boxed in Fig. 3c) , and it is clear that, as well as being sequence-related, the two proteins are very similar in overall structure and topology. A model for the Rh3OA polypeptide has been suggested which predicts 12 membrane-traversing segments with the N-terminus located in the cytoplasm (Avent et al., 1990; Cherif-Zahar et al., 1990) . On the reasonable assumption that the Rh5OA glycoprotein has the same topology, two of the potential N-glycosylation sites (Asn-37 and Asn-355) are predicted to be on the extracellular side of the membrane and are thus likely to carry N-glycan chains, whereas the site at Asn-274 is located within the cytoplasm.
The Rh5OA polypeptide does not contain any of the Cys-LeuPro (CLP) motifs found in the Rh3OA polypeptide (Avent et al., 1990) . These motifs are all likely to be on the cytoplasmic surface of the membrane and are suggested sites for palmitoylation in the Rh3OA polypeptide. Another possible palmitoylation site in the Rh3OA polypeptide is at the CCNR motif (Avent et al., 1990) (track 10), 5647C122 (track 11), clone2lE (track 12), FIR5R3 (track 13) and PCTBA1.8 (track 14) . References to the hybrids are given in Table 1 .
in the Rh5OA glycoprotein. The differences in the last extracellular loop appear to result in the Rh3OA protein having a longer final hydrophobic membrane-spanning segment. It is interesting that known sequence differences between the Rh3OA and the Rh3OB proteins also occur in the first extracellular loop (Avent et al., . The Rh50 glycoproteins are coprecipitated with the Rh30 polypeptides on immunoprecipitation with anti-D and -R6A antibodies suggesting that the two proteins are associated with each other in the erythrocyte membrane (Moore & Green, 1987; Avent et al., 1988a,b) . This association taken together with the sequence similarity of the two proteins suggests that the two proteins are different subunits of an oligomeric complex in the erythrocyte membrane. Anti-Rh D, c and E recognize different sequence epitopes and there is no evidence for sequence differences in the Rh50 glycoproteins in different Rh genotype cells (see below). Since anti-Rh D, c and E each coprecipitate the Rh50 glycoprotein with different members of the Rh30 family of proteins (Moore et al., 1982) , it is extremely unlikely that the coprecipitation of the Rh50 and Rh30 polypeptides is due to reaction of the antibodies with common epitopes on both proteins. The deficiency of several different polypeptides in RhnWi1 erythrocytes has also led to the view that the Rh antigens are part of a multimeric complex in the erythrocyte membrane (Anstee & Tanner, 1988; Avent et al., 1988b; Agre & Cartron, 1991) . The functional role of this complex is not clear but it has been suggested that it may be associated with a membrane transport process (Anstee & Tanner, 1988) , since Rhnul erythrocytes have an abnormal cation permeability (Ballas et al., 1984) . Consistent with this view, the Rh3OA and Rh5OA proteins have highly polytopic structures typically found in membrane transporters and channels. It is also of interest that two acidic residues present in the centre of the putative first and fifth membrane spans of the Rh5OA glycoprotein (Glu-13 and Glu-146, Fig. 3c ) are also conserved in the same locations in the Rh3OA polypeptide . This may be a further indication that the proteins are involved in the transfer of cationic material between the two surfaces of the membrane. The R6A45 and D50 glycoproteins The R6A45 and D50 glycoproteins are characterized by their different molecular-mass distributions in immunoprecipitates obtained using antibodies of the R6A type or anti-D respectively. This appears to result from differences in carbohydrate heterogeneity and no amino acid sequence differences have so far been detected between the two proteins. The two proteins are known to be associated with distinct polypeptides of the Rh3O group (the Rh3OA and Rh3OB polypeptides, the latter of which is involved in the expression of the D antigen, Avent et al., 1990) , and this raises the question of whether they are distinct gene products, for example the Rh5OA and Rh5OB glycoproteins, or result from differences in the processing of the N-glycan chains of a single polypeptide (Rh5OA) when it is associated with one or other of the Rh3O polypeptides. Further studies on the cloning and expression of the Rh3OB polypeptide and the putative glycoprotein corresponding to the Rh5OB DNA sequence will be required to resolve this further. Chromosomal localization of the Rh5OA gene The 1.87 kb BIA cDNA insert was used to determine the chromosomal localization of the Rh50A protein gene using DNA from a panel of human-mouse somatic cell hybrids with appropriate human and rodent controls. The probe hybridized to human EcoRI-digested genomic DNA to give two strongly hybridizing fragments of 2.5 kb and 4.2 kb and a weakly hybridizing fragment of 9 kb (Fig. 4) . In EcoRI-digested rodent control DNA, the probe detected 2.3 kb, 7.6 kb and 8.0 kb fragments in mouse (Fig. 4, tracks 3 and 7) , a single 7.0 kb fragment in rat (Fig. 4, track 4) and a 5.4 kb fragment in hamster (Fig. 4, track 5) . The human fragments were clearly distinguishable from the rodent fragments, allowing a number of somatic cell hybrids to be analysed. Using EcoRI-digested DNA from a panel of 19 human-mouse somatic cell hybrids, concordance was seen with hybrids containing human chromosome 6 ( Table 1) . The assignment was confirmed using two hybrids containing fragments of chromosome 6. MCP6 contains an X: 6 translocation (Xqter-Xql3: 6p21-qter) as the only human contribution on a mouse background . The hybrid 5647C122 contains a translocation involving chromosomes 6 and 17 [6pter-6p21 17pl3-17qter (Nagarajan et al., 1986] . MCP6 was positive (Fig. 4 , track 10) and 5647C122 was negative (Fig. 4 , track 11) confirming the assignment of the Rh5OA locus to chromosome 6, between 6p21-qter. Expression of Rh blood-group antigens and the Rh30 and Rh50 proteins The Rh30A gene has been assigned to chromosome Ip (CherifZahar et al., 1991; MacGeoch et al., 1992) and this correlates with the localization of the Rh blood-group locus to the same region of chromosome 1 by cytogenetic analysis (Bruns & Sherman, 1989) . Therefore the major different polymorphic forms of the Rh antigens (Cc, D and Ee) are specified by genetic differences in the Rh30 rather than the Rh5O proteins. It is not clear at this stage whether the structures that give rise to the Rh antigens depend solely on the Rh3O proteins or also require the association of the Rh5O glycoproteins with the Rh30 polypeptides. The Rh antigen structures could involve portions of both proteins or the Rh50 glycoproteins could be required for the correct presentation of the antigens on the Rh3O proteins.
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